These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27838625)

  • 1. Effects of Spironolactone and Renal Denervation Treatment on Blood Pressure and Its Variability-Different Aspects of Hypertension Treatment.
    Dudenbostel T; Calhoun DA
    Am J Hypertens; 2017 Jan; 30(1):12-15. PubMed ID: 27838625
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J; Widimský P; Waldauf P; Lambert L; Zelinka T; Táborský M; Branny M; Toušek P; Petrák O; Čurila K; Bednář F; Holaj R; Štrauch B; Václavík J; Nykl I; Krátká Z; Kociánová E; Jiravský O; Rappová G; Indra T; Widimský J
    Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Denervation vs. Spironolactone in Resistant Hypertension: Effects on Circadian Patterns and Blood Pressure Variability.
    de la Sierra A; Pareja J; Armario P; Barrera Á; Yun S; Vázquez S; Sans L; Pascual J; Oliveras A
    Am J Hypertens; 2017 Jan; 30(1):37-41. PubMed ID: 27650995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertension.
    Calhoun DA
    J Hypertens; 2016 Sep; 34(9):1701-3. PubMed ID: 27488549
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistant hypertension: Renal denervation or intensified medical treatment?
    Morganti A; Mancia G
    Eur J Intern Med; 2018 Apr; 50():6-11. PubMed ID: 29287767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renal denervation on short-term blood pressure variability: lack of meta-analytic evidence.
    Hering D; Grassi G
    J Hypertens; 2017 Sep; 35(9):1780-1781. PubMed ID: 28767486
    [No Abstract]   [Full Text] [Related]  

  • 8. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
    J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
    Rosa J; Widimský P; Waldauf P; Zelinka T; Petrák O; Táborský M; Branny M; Toušek P; Čurila K; Lambert L; Bednář F; Holaj R; Štrauch B; Václavík J; Kociánová E; Nykl I; Jiravský O; Rappová G; Indra T; Krátká Z; Widimský J
    J Hypertens; 2017 May; 35(5):1093-1099. PubMed ID: 28118281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
    Kiuchi MG; Chen S; Hoye NA; Pürerfellner H
    J Interv Card Electrophysiol; 2018 Jan; 51(1):51-59. PubMed ID: 29264729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistant Hypertension: Mineralocorticoid Receptor Antagonist or Renal Denervation?
    Carey RM
    Hypertension; 2016 Feb; 67(2):278-80. PubMed ID: 26693820
    [No Abstract]   [Full Text] [Related]  

  • 12. [PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension].
    Widimský J
    Vnitr Lek; 2015 Dec; 61(12):1067-71. PubMed ID: 26806502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Take a blood pressure pill or undergo renal denervation?
    Kjeldsen SE; Esler MD
    Lancet; 2018 Jun; 391(10137):2298-2300. PubMed ID: 29803587
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal denervation in uncontrolled hypertension: the story continues to unfold.
    Blankestijn PJ; Bots ML
    Lancet; 2018 Jun; 391(10137):2300-2302. PubMed ID: 29803591
    [No Abstract]   [Full Text] [Related]  

  • 16. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
    Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life and blood pressure 12 months after renal denervation.
    Lambert GW; Hering D; Marusic P; Thorp A; Sata Y; Lee R; Duval J; Hammond L; Head GA; Esler MD; Lambert EA; Dixon JB; Dhar AK; Barton DA; Schlaich MP
    J Hypertens; 2015 Nov; 33(11):2350-8. PubMed ID: 26259120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
    Ewen S; Mahfoud F; Linz D; Pöss J; Cremers B; Kindermann I; Laufs U; Ukena C; Böhm M
    Hypertension; 2014 Apr; 63(4):839-45. PubMed ID: 24420550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.